Halozyme Therapeutics Inc (HALO)

[jamtomorrow2]

FOLFIRINOX TRIAL. If 40% of the patients had high HA you would have thought that PEG plus FOLFIRINOX would have had some effect instead of what appears to be no effect. Obviously we need to see the detailed data but the initial futility readout is not what everyone was hoping for or expecting. Certainly any lingering hopes of accelerated FDA approval of PEGPH20 in combination with ABRAXANE® and gemcitabine seem to have been dashed with this latest setback. Maybe PEG doesn't work in a statistically significant way.